Kolexia
Dargaud Yesim Biologie médicale
Dargaud Yesim
Biologie médicale
Hôpital Louis Pradel
Bron, France
172 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Hémorragie Thrombose Hémophilie B Thromboembolisme veineux Thromboembolie Thrombose veineuse Déficit en facteur XI COVID-19

Collaborateurs

Voir plus
Negrier Claude
Negrier Claude
Hôpital Louis Pradel, Bron, France
Lienhart Anne
Lienhart Anne
Hôpital Louis Pradel, Bron, France
Nougier Christophe
Nougier Christophe
Hôpital Femme Mère Enfant, Bron, France
Meunier Sandrine
Meunier Sandrine
Hôpital Louis Pradel, Bron, France

Industries

Voir plus
Sobi
10 collaboration(s)
Dernière en 2023
LFB
6 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
5 collaboration(s)
Dernière en 2022
Leo Pharma
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
PRESent-2: A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B
Essai Clinique (ApcinteX Ltd)   15 mars 2024
PRESent-3: A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With Inhibitors
Essai Clinique (ApcinteX Ltd)   04 mars 2024
"Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery": reply.
Journal of thrombosis and haemostasis : JTH   01 mars 2024
LYON SAPL: Domain 1 of β2-Glycoprotein 1 Autoantibodies and Thrombin Generation Capacity in Patients With Antiphospholipid Antibodies
Essai Clinique (Hospices Civils de Lyon)   27 février 2024
PRESCOT: Prospective Multicentre Randomized Clinical Trial on the Management of Pregnancies With High Risk of Venous Thrombosis
Essai Clinique (Hospices Civils de Lyon)   27 février 2024
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapy.
Haematologica   15 février 2024
Eptacog beta for the management of patients with haemophilia A and B with inhibitors: A European perspective.
Haemophilia : the official journal of the World Federation of Hemophilia   05 février 2024
Tailoring a specific medical leadership development program for faculty members: the Lyon-Ottawa experience.
Medical education online   30 janvier 2024
Blood-Induced Arthropathy: A Major Disabling Complication of Haemophilia.
Journal of clinical medicine   30 décembre 2023
Comparison of one-stage and chromogenic factor VIII assays to tailor the dose of recombinant factor VIII-Fc fusion protein (rFVIIIFc, efmoroctocog alfa) in adult patients with haemophilia A: Single-centre, real-world experience of surgery.
Haemophilia : the official journal of the World Federation of Hemophilia   27 décembre 2023